The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Equine Chorionic Gonadotropin (eCG) Market Research Report 2025
Synopsis
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
The global Equine Chorionic Gonadotropin (eCG) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Equine Chorionic Gonadotropin (eCG) include MSD Animal Health, Phiphar Healthcare Limited, RayBiotech, Ceva Santé Animale, Antech, Gansu Tianqi Biological Technology, Xiamen Origin Biotech, Cixi No.2 Hormones Factory and Biorigin (Beijing) Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Equine Chorionic Gonadotropin (eCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Chorionic Gonadotropin (eCG).
Report Scope
The Equine Chorionic Gonadotropin (eCG) market size, estimations, and forecasts are provided in terms of sales volume (M IU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Chorionic Gonadotropin (eCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Chorionic Gonadotropin (eCG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD Animal Health
Phiphar Healthcare Limited
RayBiotech
Ceva Santé Animale
Antech
Gansu Tianqi Biological Technology
Xiamen Origin Biotech
Cixi No.2 Hormones Factory
Biorigin (Beijing) Inc.
Segment by Type
Lyophilized Powder
Liquid Form
Segment by Application
Infertility Treatment
Reproduction Assistance
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Chorionic Gonadotropin (eCG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Equine chorionic gonadotropin (eCG), also known as pregnant mare serum gonadotropin (PMSG) or equine luteinizing hormone. Equine chorionic gonadotropin is a gonadotropic hormone produced in the chorion of pregnant mares. It is a glycoprotein hormone secreted by fetal-origin trophoblastic epithelial cells that form the endometrial cups.
The global Equine Chorionic Gonadotropin (eCG) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Equine Chorionic Gonadotropin (eCG) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Equine Chorionic Gonadotropin (eCG) include MSD Animal Health, Phiphar Healthcare Limited, RayBiotech, Ceva Santé Animale, Antech, Gansu Tianqi Biological Technology, Xiamen Origin Biotech, Cixi No.2 Hormones Factory and Biorigin (Beijing) Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Equine Chorionic Gonadotropin (eCG), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Equine Chorionic Gonadotropin (eCG).
Report Scope
The Equine Chorionic Gonadotropin (eCG) market size, estimations, and forecasts are provided in terms of sales volume (M IU) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Equine Chorionic Gonadotropin (eCG) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Equine Chorionic Gonadotropin (eCG) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
MSD Animal Health
Phiphar Healthcare Limited
RayBiotech
Ceva Santé Animale
Antech
Gansu Tianqi Biological Technology
Xiamen Origin Biotech
Cixi No.2 Hormones Factory
Biorigin (Beijing) Inc.
Segment by Type
Lyophilized Powder
Liquid Form
Segment by Application
Infertility Treatment
Reproduction Assistance
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Equine Chorionic Gonadotropin (eCG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Equine Chorionic Gonadotropin (eCG) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Equine Chorionic Gonadotropin (eCG) Market Overview
1.1 Product Overview and Scope of Equine Chorionic Gonadotropin (eCG)
1.2 Equine Chorionic Gonadotropin (eCG) Segment by Type
1.2.1 Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2024-2030)
1.2.2 Lyophilized Powder
1.2.3 Liquid Form
1.3 Equine Chorionic Gonadotropin (eCG) Segment by Application
1.3.1 Global Equine Chorionic Gonadotropin (eCG) Market Value by Application: (2024-2030)
1.3.2 Infertility Treatment
1.3.3 Reproduction Assistance
1.4 Global Equine Chorionic Gonadotropin (eCG) Market Size Estimates and Forecasts
1.4.1 Global Equine Chorionic Gonadotropin (eCG) Revenue 2019-2030
1.4.2 Global Equine Chorionic Gonadotropin (eCG) Sales 2019-2030
1.4.3 Global Equine Chorionic Gonadotropin (eCG) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Equine Chorionic Gonadotropin (eCG) Market Competition by Manufacturers
2.1 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Equine Chorionic Gonadotropin (eCG) Average Price by Manufacturers (2019-2024)
2.4 Global Equine Chorionic Gonadotropin (eCG) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Product Type & Application
2.7 Equine Chorionic Gonadotropin (eCG) Market Competitive Situation and Trends
2.7.1 Equine Chorionic Gonadotropin (eCG) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Equine Chorionic Gonadotropin (eCG) Players Market Share by Revenue
2.7.3 Global Equine Chorionic Gonadotropin (eCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Equine Chorionic Gonadotropin (eCG) Retrospective Market Scenario by Region
3.1 Global Equine Chorionic Gonadotropin (eCG) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Equine Chorionic Gonadotropin (eCG) Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2019-2030
3.2.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2019-2024
3.2.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Region: 2025-2030
3.3 Global Equine Chorionic Gonadotropin (eCG) Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2019-2030
3.3.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2019-2024
3.3.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2025-2030
3.4 North America Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.4.1 North America Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2030)
3.4.3 North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.5.1 Europe Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2030)
3.5.3 Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.6.1 Asia Pacific Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2030)
3.6.3 Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.7.1 Latin America Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2030)
3.7.3 Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Market Facts & Figures by Country
3.8.1 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2019-2030)
4.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2019-2024)
4.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Type (2025-2030)
4.1.3 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2019-2030)
4.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2019-2030)
4.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2019-2024)
4.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Type (2025-2030)
4.2.3 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2019-2030)
4.3 Global Equine Chorionic Gonadotropin (eCG) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2019-2030)
5.1.1 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2019-2024)
5.1.2 Global Equine Chorionic Gonadotropin (eCG) Sales by Application (2025-2030)
5.1.3 Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2019-2030)
5.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2019-2030)
5.2.1 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2019-2024)
5.2.2 Global Equine Chorionic Gonadotropin (eCG) Revenue by Application (2025-2030)
5.2.3 Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2019-2030)
5.3 Global Equine Chorionic Gonadotropin (eCG) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 MSD Animal Health
6.1.1 MSD Animal Health Corporation Information
6.1.2 MSD Animal Health Description and Business Overview
6.1.3 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.1.5 MSD Animal Health Recent Developments/Updates
6.2 Phiphar Healthcare Limited
6.2.1 Phiphar Healthcare Limited Corporation Information
6.2.2 Phiphar Healthcare Limited Description and Business Overview
6.2.3 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.2.5 Phiphar Healthcare Limited Recent Developments/Updates
6.3 RayBiotech
6.3.1 RayBiotech Corporation Information
6.3.2 RayBiotech Description and Business Overview
6.3.3 RayBiotech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 RayBiotech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.3.5 RayBiotech Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 Antech
6.5.1 Antech Corporation Information
6.5.2 Antech Description and Business Overview
6.5.3 Antech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Antech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.5.5 Antech Recent Developments/Updates
6.6 Gansu Tianqi Biological Technology
6.6.1 Gansu Tianqi Biological Technology Corporation Information
6.6.2 Gansu Tianqi Biological Technology Description and Business Overview
6.6.3 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.6.5 Gansu Tianqi Biological Technology Recent Developments/Updates
6.7 Xiamen Origin Biotech
6.6.1 Xiamen Origin Biotech Corporation Information
6.6.2 Xiamen Origin Biotech Description and Business Overview
6.6.3 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.7.5 Xiamen Origin Biotech Recent Developments/Updates
6.8 Cixi No.2 Hormones Factory
6.8.1 Cixi No.2 Hormones Factory Corporation Information
6.8.2 Cixi No.2 Hormones Factory Description and Business Overview
6.8.3 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.8.5 Cixi No.2 Hormones Factory Recent Developments/Updates
6.9 Biorigin (Beijing) Inc.
6.9.1 Biorigin (Beijing) Inc. Corporation Information
6.9.2 Biorigin (Beijing) Inc. Description and Business Overview
6.9.3 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product Portfolio
6.9.5 Biorigin (Beijing) Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Equine Chorionic Gonadotropin (eCG) Industry Chain Analysis
7.2 Equine Chorionic Gonadotropin (eCG) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Equine Chorionic Gonadotropin (eCG) Production Mode & Process
7.4 Equine Chorionic Gonadotropin (eCG) Sales and Marketing
7.4.1 Equine Chorionic Gonadotropin (eCG) Sales Channels
7.4.2 Equine Chorionic Gonadotropin (eCG) Distributors
7.5 Equine Chorionic Gonadotropin (eCG) Customers
8 Equine Chorionic Gonadotropin (eCG) Market Dynamics
8.1 Equine Chorionic Gonadotropin (eCG) Industry Trends
8.2 Equine Chorionic Gonadotropin (eCG) Market Drivers
8.3 Equine Chorionic Gonadotropin (eCG) Market Challenges
8.4 Equine Chorionic Gonadotropin (eCG) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Equine Chorionic Gonadotropin (eCG) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) of Key Manufacturers (2019-2024)
Table 5. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Equine Chorionic Gonadotropin (eCG) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Equine Chorionic Gonadotropin (eCG) Average Price (US$/IU) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Equine Chorionic Gonadotropin (eCG), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Product Type & Application
Table 12. Global Key Manufacturers of Equine Chorionic Gonadotropin (eCG), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Equine Chorionic Gonadotropin (eCG) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Equine Chorionic Gonadotropin (eCG) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Equine Chorionic Gonadotropin (eCG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Equine Chorionic Gonadotropin (eCG) Sales by Region (2019-2024) & (M IU)
Table 18. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2019-2024)
Table 19. Global Equine Chorionic Gonadotropin (eCG) Sales by Region (2025-2030) & (M IU)
Table 20. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2025-2030)
Table 21. Global Equine Chorionic Gonadotropin (eCG) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2019-2024)
Table 23. Global Equine Chorionic Gonadotropin (eCG) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2025-2030)
Table 25. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2024) & (M IU)
Table 27. North America Equine Chorionic Gonadotropin (eCG) Sales by Country (2025-2030) & (M IU)
Table 28. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2024) & (M IU)
Table 32. Europe Equine Chorionic Gonadotropin (eCG) Sales by Country (2025-2030) & (M IU)
Table 33. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Equine Chorionic Gonadotropin (eCG) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Region (2019-2024) & (M IU)
Table 37. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales by Region (2025-2030) & (M IU)
Table 38. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2024) & (M IU)
Table 42. Latin America Equine Chorionic Gonadotropin (eCG) Sales by Country (2025-2030) & (M IU)
Table 43. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Equine Chorionic Gonadotropin (eCG) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2019-2024) & (M IU)
Table 47. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales by Country (2025-2030) & (M IU)
Table 48. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Type (2019-2024)
Table 51. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Type (2025-2030)
Table 52. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2019-2024)
Table 53. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Type (2025-2030)
Table 54. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2019-2024)
Table 57. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Type (2025-2030)
Table 58. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2019-2024)
Table 59. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2025-2030)
Table 60. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Application (2019-2024)
Table 61. Global Equine Chorionic Gonadotropin (eCG) Sales (M IU) by Application (2025-2030)
Table 62. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2019-2024)
Table 63. Global Equine Chorionic Gonadotropin (eCG) Sales Market Share by Application (2025-2030)
Table 64. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Equine Chorionic Gonadotropin (eCG) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2019-2024)
Table 67. Global Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Application (2025-2030)
Table 68. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2019-2024)
Table 69. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2025-2030)
Table 70. MSD Animal Health Corporation Information
Table 71. MSD Animal Health Description and Business Overview
Table 72. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 73. MSD Animal Health Equine Chorionic Gonadotropin (eCG) Product
Table 74. MSD Animal Health Recent Developments/Updates
Table 75. Phiphar Healthcare Limited Corporation Information
Table 76. Phiphar Healthcare Limited Description and Business Overview
Table 77. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 78. Phiphar Healthcare Limited Equine Chorionic Gonadotropin (eCG) Product
Table 79. Phiphar Healthcare Limited Recent Developments/Updates
Table 80. RayBiotech Corporation Information
Table 81. RayBiotech Description and Business Overview
Table 82. RayBiotech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 83. RayBiotech Equine Chorionic Gonadotropin (eCG) Product
Table 84. RayBiotech Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 88. Ceva Santé Animale Equine Chorionic Gonadotropin (eCG) Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. Antech Corporation Information
Table 91. Antech Description and Business Overview
Table 92. Antech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 93. Antech Equine Chorionic Gonadotropin (eCG) Product
Table 94. Antech Recent Developments/Updates
Table 95. Gansu Tianqi Biological Technology Corporation Information
Table 96. Gansu Tianqi Biological Technology Description and Business Overview
Table 97. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 98. Gansu Tianqi Biological Technology Equine Chorionic Gonadotropin (eCG) Product
Table 99. Gansu Tianqi Biological Technology Recent Developments/Updates
Table 100. Xiamen Origin Biotech Corporation Information
Table 101. Xiamen Origin Biotech Description and Business Overview
Table 102. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 103. Xiamen Origin Biotech Equine Chorionic Gonadotropin (eCG) Product
Table 104. Xiamen Origin Biotech Recent Developments/Updates
Table 105. Cixi No.2 Hormones Factory Corporation Information
Table 106. Cixi No.2 Hormones Factory Description and Business Overview
Table 107. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 108. Cixi No.2 Hormones Factory Equine Chorionic Gonadotropin (eCG) Product
Table 109. Cixi No.2 Hormones Factory Recent Developments/Updates
Table 110. Biorigin (Beijing) Inc. Corporation Information
Table 111. Biorigin (Beijing) Inc. Description and Business Overview
Table 112. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Sales (M IU), Revenue (US$ Million), Price (US$/IU) and Gross Margin (2019-2024)
Table 113. Biorigin (Beijing) Inc. Equine Chorionic Gonadotropin (eCG) Product
Table 114. Biorigin (Beijing) Inc. Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Equine Chorionic Gonadotropin (eCG) Distributors List
Table 118. Equine Chorionic Gonadotropin (eCG) Customers List
Table 119. Equine Chorionic Gonadotropin (eCG) Market Trends
Table 120. Equine Chorionic Gonadotropin (eCG) Market Drivers
Table 121. Equine Chorionic Gonadotropin (eCG) Market Challenges
Table 122. Equine Chorionic Gonadotropin (eCG) Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Equine Chorionic Gonadotropin (eCG)
Figure 2. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Equine Chorionic Gonadotropin (eCG) Market Share by Type in 2023 & 2030
Figure 4. Lyophilized Powder Product Picture
Figure 5. Liquid Form Product Picture
Figure 6. Global Equine Chorionic Gonadotropin (eCG) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Equine Chorionic Gonadotropin (eCG) Market Share by Application in 2023 & 2030
Figure 8. Infertility Treatment
Figure 9. Reproduction Assistance
Figure 10. Global Equine Chorionic Gonadotropin (eCG) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Equine Chorionic Gonadotropin (eCG) Market Size (2019-2030) & (US$ Million)
Figure 12. Global Equine Chorionic Gonadotropin (eCG) Sales (2019-2030) & (M IU)
Figure 13. Global Equine Chorionic Gonadotropin (eCG) Average Price (US$/IU) & (2019-2030)
Figure 14. Equine Chorionic Gonadotropin (eCG) Report Years Considered
Figure 15. Equine Chorionic Gonadotropin (eCG) Sales Share by Manufacturers in 2023
Figure 16. Global Equine Chorionic Gonadotropin (eCG) Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Equine Chorionic Gonadotropin (eCG) Players: Market Share by Revenue in 2023
Figure 18. Equine Chorionic Gonadotropin (eCG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Equine Chorionic Gonadotropin (eCG) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2019-2030)
Figure 21. North America Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2019-2030)
Figure 22. United States Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2019-2030)
Figure 25. Europe Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2019-2030)
Figure 26. Germany Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Netherlands Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Equine Chorionic Gonadotropin (eCG) Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Region (2019-2030)
Figure 33. China Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. China Taiwan Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Latin America Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2019-2030)
Figure 41. Latin America Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2019-2030)
Figure 42. Mexico Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Brazil Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Argentina Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Colombia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Sales Market Share by Country (2019-2030)
Figure 47. Middle East & Africa Equine Chorionic Gonadotropin (eCG) Revenue Market Share by Country (2019-2030)
Figure 48. Turkey Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Saudi Arabia Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. UAE Equine Chorionic Gonadotropin (eCG) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) by Type (2019-2030)
Figure 52. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) by Type (2019-2030)
Figure 53. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Type (2019-2030)
Figure 54. Global Sales Market Share of Equine Chorionic Gonadotropin (eCG) by Application (2019-2030)
Figure 55. Global Revenue Market Share of Equine Chorionic Gonadotropin (eCG) by Application (2019-2030)
Figure 56. Global Equine Chorionic Gonadotropin (eCG) Price (US$/IU) by Application (2019-2030)
Figure 57. Equine Chorionic Gonadotropin (eCG) Value Chain
Figure 58. Equine Chorionic Gonadotropin (eCG) Production Process
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Distributors Profiles
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
